1型妊婦でのインスリンデグルデク安全性 (EXPECT)

★★★

Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial. Lancet Diabetes Endocrinol. 2023 Feb;11(2):86-95. doi: 10.1016/S2213-8587(22)00307-2. Epub 2023 Jan 6. Erratum in: Lancet Diabetes Endocrinol. 2023 May;11(5):e7. Erratum in: Lancet Diabetes Endocrinol. 2023 Aug;11(8):e10. PMID: 36623517.

23/1/6

Lancet DE

Pubmed

介入試験

1型妊婦225人。デグルデク vs デテミル。
A1cは非劣性。安全性は同等と判断。